Identifying gp85- regions involved in Epstein- Barr virus binding to Blymphocytes.

Date
2004Author
Urquiza, MauricioSuarez, Jorge
Lopez, Ramses
Vega, Erika
Patiño, Helena
Garcia, Javier
Patarroyo, Manuel A.
Guzman, Fanny
Patarroyo, Manuel E.
Métricas
Share
Citation
URI
https://doi.org/10.1016/j.bbrc.2004.04.177https://repository.urosario.edu.co/handle/10336/27839
Abstract
"Epstein–Barr virus lacking glycoprotein gp85 cannot infect B-cells and epithelial cells. The gp85 belongs to the molecular complex required for virus invasion of B-lymphocyte or epithelial cells. Moreover, there is evidence that gp85 is necessary for virus attachment to epithelial cells. Thirty-six peptides from the entire gp85-sequence were tested in epithelial and lymphoblastoid cell line binding assays to identify gp85-regions involved in virus–cell interaction. Five of these peptides presented high binding activity to Raji, Ramos, P3HR-1, and HeLa cells, but not to erythrocytes; Raji-cell affinity constants were between 80 and 140 nM. Of these five peptides, 11435 (181TYKRVTEKGDEHVLSLVFGK200), 11436 (201TKDLPDLRGPFSYPSLTSAQ220), and 11438 (241YFVPNLKDMFSRAVTMTAAS260) bound to a 65 kDa protein on Raji-cell surface. These peptides and antibodies induced by them (recognising live EBV-infected cells) inhibited Epstein–Barr virus interaction with cord blood lymphocytes. It is thus probable that gp85-regions defined by peptides 11435, 11436, and 11438 are involved in EBV invasion of B-lymphocytes."
Collections
- Artículos [6079]